Skip to content

Baxter International BAX Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options

Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options at other companies

T Rowe Price Group logo
T Rowe Price GroupTROW
$100K-99.3%
IQVIA logo
IQVIAIQV
$16.75M+4.7%
CoStar Group logo
CoStar GroupCSGP
$14M+100%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$9.98M-41.4%
Paychex logo
PaychexPAYX
-$1.8M-137%
Snap-on logo
Snap-onSNA
$30.6M+67.2%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
Baxter International (BAX) reported proceeds from issuance of shares under incentive and share based compensation plans including stock options of $8M in Q1 2026.
How has Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options changed year-over-year?
Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options decreased by 20.0% year-over-year, from $10M to $8M.
What is the long-term trend for Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
Over 4 years (2021 to 2025), Baxter International's proceeds from issuance of shares under incentive and share based compensation plans including stock options has grown at a -36.7% compound annual growth rate (CAGR), from $187M to $30M.
What does proceeds from issuance of shares under incentive and share based compensation plans including stock options mean?
Cash received when employees exercise stock options or purchase shares through company plans.
How do you interpret proceeds from issuance of shares under incentive and share based compensation plans including stock options?
Higher proceeds indicate increased employee participation in equity plans, which can align employee interests with shareholders but also result in share dilution.
How does proceeds from issuance of shares under incentive and share based compensation plans including stock options compare across companies?
Standard financing activity metric for companies with equity compensation programs.